Kenaitx
Founded 2022 · 40 employees on LinkedIn · 2 known investors
Find your way into Kenaitx
709 people in our graph share verified history with the Kenaitx team — schools, employers, funds. One of them is your warm intro.
Diana Berishaunlockedknows Howard J. Federoff · together at Georgetown (overlapped)
%20(1)%20(1).png)
×11knows the team · via Georgetown
Kenai Therapeutics develops iPSC-derived cell therapies and gene-modified medicines for neurodegenerative diseases, particularly Parkinson's disease, leveraging induced pluripotent stem cell technology to replace damaged neurons and restore neural function.
Founders & leadership
Kenaitx was founded in 2022 by Howard Federoff.
HF
Howard FederoffinScientific Co-Founder, Chief Medical Officer and Executive Vice President of Corporate Medicine and ScienceHoward Federoff holds an MD and PhD from Albert Einstein College of Medicine and has held senior leadership roles in biotech and higher education with expertise in cell and gene therapy, cognitive biomarkers, and advanced biologics approaches to neurological disease. He is Scientific Co-Founder and Chief Medical Officer of Kenai Therapeutics, which develops cell therapies derived from induced pluripotent stem cells for neurodegenerative diseases.
Investors · 2
Frequently asked questions
- What does Kenaitx do?
- Kenai Therapeutics develops iPSC-derived cell therapies and gene-modified medicines for neurodegenerative diseases, particularly Parkinson's disease, leveraging induced pluripotent stem cell technology to replace damaged neurons and restore neural function.
- Who founded Kenaitx?
- Kenaitx was founded by Howard Federoff in 2022.
- Who are Kenaitx's investors?
- Kenaitx's investors include Cure Ventures, The Column Group.